For five of these patients, the ERBB2 mutation identified in plasma could also be detected in tumor tissues (L755S for patient #17, V777L for patient #162, V777L for patient #167, L869R for patient #227, and V777L for patient #229). Here, ERBB2 is linked to neoplasm.